BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954 AND Diagnosis
62 results:

  • 1. The influence of marital status at diagnosis on survival of adult patients with mantle cell lymphoma.
    Zhang T; Wang ZT; Li Z; Yin SX; Wang X; Chen HZ
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):120. PubMed ID: 38466431
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Rate of Pathogenic Germline Variants in Patients With Lung cancer.
    Sorscher S; LoPiccolo J; Heald B; Chen E; Bristow SL; Michalski ST; Nielsen SM; Lacoste A; Keyder E; Lee H; Nussbaum RL; Martins R; Esplin ED
    JCO Precis Oncol; 2023 Sep; 7():e2300190. PubMed ID: 37992258
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Bilateral Lacrimal Gland Mantle Cell Lymphoma in 11-Year Follow-Up: Case Report and Review of 48 Cases With Ocular Adnexal Presentation in the Literature.
    Matsuo T; Tanaka T; Okada K; Notohara K; Fujii K; Fujii N
    J Investig Med High Impact Case Rep; 2023; 11():23247096231185483. PubMed ID: 37403948
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Access disparities and underutilization of germline genetic testing in Chilean breast cancer patients.
    Acevedo F; Walbaum B; Camus M; Manzor M; Muñiz S; Medina L; Petric M; Reyes P; Domínguez F; Puschel K; Merino T; Bravo ML; Pinto MP; Ibáñez C; Hughes K; Sánchez C
    Breast Cancer Res Treat; 2023 Jun; 199(2):363-370. PubMed ID: 36988750
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Family History of Prostate cancer and Survival Outcomes in the UK Genetic Prostate cancer Study.
    Brook MN; Ní Raghallaigh H; Govindasami K; Dadaev T; Rageevakumar R; Keating D; Hussain N; Osborne A; Lophatananon A; ; Muir KR; Kote-Jarai Z; Eeles RA
    Eur Urol; 2023 Mar; 83(3):257-266. PubMed ID: 36528478
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Evaluation of family history in individuals with heterozygous BRCA pathogenic variants diagnosed with breast or ovarian cancer in a single center in Italy.
    Negri S; De Ponti E; Sina FP; Sala E; Dell'Oro C; Roversi G; Lazzarin S; Delle Marchette M; Inzoli A; Toso C; Fumagalli S; Campanella M; Kotsopoulos J; Fruscio R
    Mol Genet Genomic Med; 2022 Dec; 10(12):e2071. PubMed ID: 36307994
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Do breast cancer survivors with a recent history of clinical depression report worse experiences with care? A retrospective cohort study using SEER-CAHPS data.
    Arevalo M; Pickering TA; Vernon SW; Fujimoto K; Peskin MF; Farias AJ
    Cancer Med; 2023 Jan; 12(2):1949-1960. PubMed ID: 35929584
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Routine clinical parameters and laboratory testing predict therapy-related myeloid neoplasms after treatment for breast cancer.
    Petrone G; Gaulin C; Derkach A; Kishtagari A; Robson ME; Parameswaran R; Stein EM
    Haematologica; 2023 Jan; 108(1):161-170. PubMed ID: 35770528
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Significance of prostate/pancreatic/skin cancer family history for detecting BRCA2 pathogenic variant careers among patients with breast cancer.
    Minoura Y; Takahashi M; Maeda H; Kuwahara S; Tachikawa H; Yamamoto M; Tomioka N; Watanabe K; Sakurai A
    Breast Cancer; 2022 Sep; 29(5):808-813. PubMed ID: 35641852
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Uterine leiomyoma with fumarate hydratase deficiency: A case report.
    Huang Y; Zhou Y; Chen X; Fang Q; Cai H; Xie M; Xing Y
    Medicine (Baltimore); 2021 Dec; 100(49):e28142. PubMed ID: 34889279
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors.
    Lee A; Yang X; Tyrer J; Gentry-Maharaj A; Ryan A; Mavaddat N; Cunningham AP; Carver T; Archer S; Leslie G; Kalsi J; Gaba F; Manchanda R; Gayther S; Ramus SJ; Walter FM; Tischkowitz M; Jacobs I; Menon U; Easton DF; Pharoah P; Antoniou AC
    J Med Genet; 2022 Jul; 59(7):632-643. PubMed ID: 34844974
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Identification of women at risk of hereditary breast-ovarian cancer among participants in a population-based breast cancer screening.
    Bonelli L; Valle I; Rebora I; Ricci P; Biocchi L; Bruschi G; Parodi S; Bruzzone C; Varesco L
    Fam Cancer; 2022 Jul; 21(3):309-318. PubMed ID: 34669096
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Germline and tumor BRCA1/2 pathogenic variants in Chinese triple-negative breast carcinomas.
    Ji G; Bao L; Yao Q; Zhang J; Zhu X; Bai Q; Shao Z; Yang W; Zhou X
    J Cancer Res Clin Oncol; 2021 Oct; 147(10):2935-2944. PubMed ID: 34254208
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Patient with Lobular Carcinoma of the breast and Activating AKT1 E17K Variant.
    Trivedi H; Hamdani O; Thomas B; Richard J; Shah K; Raskina K; Zhang L; Madigan A; Fox M; Wander S; Frigault MJ; Alexander B; Srkalovic G
    Acta Med Acad; 2021 Apr; 50(1):209-217. PubMed ID: 34075774
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients.
    Sabol RA; Ledet EM; Jaeger E; Hatton W; Moses M; Lankford A; Zaheria A; Barata P; Layton JL; Lewis BE; Sartor O
    Prostate; 2021 May; 81(7):427-432. PubMed ID: 33760238
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Cowden syndrome: new clinical features in a large family; joint hyperextensibility, dental abnormalities and gingival enlargement.
    Sabir A; Parry G; Heaton T; Ong KR
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33692038
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Patterns of cancer family history and genetic counseling eligibility among African Americans with breast, prostate, lung, and colorectal cancers: A Detroit Research on cancer Survivors cohort study.
    Purrington KS; Schwartz AG; Ruterbusch JJ; Manning MA; Nair M; Wenzlaff AS; Pandolfi SS; Simon MS; Beebe-Dimmer J
    Cancer; 2020 Nov; 126(21):4744-4752. PubMed ID: 32749684
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Impact of family history risk assessment on surgical decisions and imaging surveillance at breast cancer diagnosis.
    Jones S; Turton P; Achuthan R
    Ann R Coll Surg Engl; 2020 Oct; 102(8):590-593. PubMed ID: 32436722
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Revisiting the Genomic and Transcriptomic Landscapes from Female Malignancies Could Provide Molecular Markers and Targets for Precision Medicine.
    Taniguchi-Ponciano K; Huerta-Padilla V; Baeza-Xochihua V; Ponce-Navarrete G; Salcedo E; Gomez-Apo E; Chavez-Macias L; Aviles-Duran J; Ruiz-Sanchez H; Valdivia A; Peralta R; Romero-Anduaga H; Rosas-Vargas H; Quijano F; Salcedo M; Marrero-Rodríguez D
    Arch Med Res; 2019 Oct; 50(7):428-436. PubMed ID: 31783305
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Differential Profile of BRCA1 vs. BRCA2 Mutated Families: A Characterization of the Main Differences and Similarities in Patients.
    Fernandes GC; Felicio PS; Michelli RAD; Coelho AS; Scapulatempo-Neto C; Palmero EI
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1655-1660. PubMed ID: 31244284
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.